Abstract: Breast cancer is the most prevalent female cancer in the US. Incidence rates are similar for white and black women but mortality rates are higher for black women. This study draws on rich, nationally representative data, the 2008-2015 Medical Expenditure Panel Surveys, to estimate effects of the Affordable Care Act (ACA) on reducing disparities in and access to use of diagnostic and medical services for black and Hispanic breast cancer survivors. Random effects multinomial logit, flexible hurdle and Box-Cox estimation techniques are used. The robust estimates indicate that the ACA narrowed the racial/ethnic disparity in health insurance coverage, health care utilization and out-of-pocket prescription drug expenditures among breast cancer survivors. Gaps in uninsurance significantly declined for black and Hispanic survivors. Hispanic women generally and black breast cancer survivors specifically increased use of mammography services post-ACA. The ACA did not significantly impact disparities in physician utilization or out-of-pocket prescription drug expenditures for Hispanic survivors, while there were substantive improvements for black breast cancer survivors. The paper concludes with a discussion of the strengths and limitations of the ACA for reducing disparities and improving health outcomes for a growing population of breast cancer survivors in the US.
Introduction
Breast cancer is the leading type of cancer among women of all racial and ethnic groups in the US. Although the most recent data confirm the converging incidence of breast cancer between non-Hispanic blacks (NHB) and non-Hispanic whites (NHW) [1] , there are substantial disparities in breast cancer mortality between NHB and NHW. The breast cancer mortality differential between NHB and NHW women has persisted for decades. In 2012, for instance, mortality rates were 42% higher for NHB women [2] . While Hispanic women have a lower mortality and incidence rate for breast cancer than NHW and NHB women. Nonetheless, current trends in incidence rates for Hispanic women suggest concerns about future ethnic inequities in breast health outcomes. This is because from 2005 to 2014 incidence rates for Hispanic women have grown 0.3 percent each year and those of NHW women have remained stable [2] .
Biological, environmental and health system factors are possible sources of these disparities. Specifically, differences in breast cancer incidence, tumor type and pathological stage at diagnosis,
The ACA and Continuity of Care for Breast Patients
Finally, provisions associated with continuity of care are; (1) insurance companies were not able to put an annual or lifetime limit on coverage for patients with breast cancer; (2) insurance companies were not able to drop an individual from a health insurance plan because he or she had breast cancer; and (3) Medicare beneficiaries received discounts on brand-name drugs. Additionally, the prescription coverage gap created by the Medicare Part D "doughnut hole" is planned for complete closure by 2020.
Based on these changes implemented via the ACA, we test the following hypothesis. Due to the implementation of the ACA, these changes will occur: (1) an increase in health insurance coverage for breast cancer survivors post-ACA; (2) a decline in the number of uninsured breast cancer survivors; (3) an increase in use of mammograms by all women, especially breast cancer survivors; (4) an increase in the use of curative services (e.g., doctor visits) among survivors and (5) a decrease in out-of-pocket prescription drug expenditures among survivors post-ACA.
Materials and Methods

Data Sources
The current study utilizes the Medical Expenditure Panel Survey (MEPS) 2008-2015 datasets. MEPS is an annual survey of civilian and non-institutionalized US citizens funded by the Agency for Healthcare Research and Quality (AHRQ) since 1996. The MEPS datasets provide detailed information about the users and providers of health care services through household and insurance components, respectively [18] . The household component includes rich information on the use of health services, health expenditures, insurance plans and demographics of the survey respondents. With an overlapping design and five rounds of surveys (one baseline and four follow-ups), MEPS allows pooled cross sectional and short-panel analysis.
The key variables of interest are indicator variables that show pre-and post-ACA implementation periods. We separate the post-ACA period into two sub-periods. Sub-period A covers years 2010, 2011, 2012 and 2013, while sub-period B includes years 2014 and 2015. The 2008-2009 period is considered as the pre-ACA period and compared to both sub-periods. We include two post-ACA time periods because not all of the ACA provisions related to breast health outcomes were implemented in 2010; access related provisions 2-4 and the continuity of care provision number 3 were not implemented until 2014. Additionally, given concerns that the Great Recession of 2008 and its aftermath might confound the before-after comparison, we include a comparison between the pre-ACA period and the 2014-2015 period. The main outcome variables are health insurance type (public insurance, private insurance and uninsured), use of mammograms, number of physician visits and prescription drug expenditures. A set of demographic and socio-economic variables are included as independent variables. Table 1 shows the descriptive statistics of variables. Each of the regression models includes variables indicating region, MSA, demographic factors (age, marital status, education) and family income. The health status variable is only included in the health insurance regression model. The insurance regression also includes number of comorbidities. The mammography usage and outpatient regressions include an employment status variable. Inclusion and exclusion of regressors in the models are based upon prior research and certain statistical procedures (e.g., testing for multicollinearity, correlation coefficient and normality assumptions).
Statistical Analysis
Several statistical measures are considered to explore the impact of the ACA on the health insurance coverage and utilization of preventive and curative health care services for breast cancer survivors. To better understand the ACA's role, we separate our analysis for each racial and ethnic group; namely NHW, NHB and Hispanics. Initially, to explore the longitudinal patterns of influence, we present data in descriptive form using linear graphs. Thereafter, depending on the distribution of the dependent variables in the regressions, multinomial logit, flexible hurdle and Box-Cox statistical techniques are empirically implemented to robustly estimate the effects of the ACA on health insurance coverage, use of mammography, utilization of physician services and out-of-pocket prescription drug expenditures, respectively.
To test the hypothesis associated with the occurrence of health insurance transition pre-and post ACA we apply a random effects multinomial logistic (MNL) regression. MNL models are used when the dependent variable is categorically distributed and contain multiple choices (more than two choices). Unlike standard multinomial logit models that assume independence within a choice (multiple data points for the same choice over time) and across all the alternative choices over time, akin to Alem, et al. [19] , our model relaxes the assumption of independency of multiple observations within a choice. Another important identification issue is presence of individual level heterogeneity that random effects MNL has the capability to address appropriately. We estimate the following equation:
where, y jit is the type of health insurance j held by individual i at time t and x it is a vector of independent variables and υ jit is idiosyncratic error that follows independent and identical distribution. D t , is a binary variable that shows the pre-and post-ACA periods. Finally, η ji is individual-specific random effects that capture unobserved heterogeneity. In our model, the choice of holding private health insurance is considered as comparison group. To test the hypothesis on the use of mammogram pre-and post-ACA, we empirically estimate random effects logistic regression. Here the dependent variable is dichotomous. The woman was asked if she had a mammogram in the last two years. If the response is yes, we coded it 1 and otherwise 0. The empirical model takes the following form:
where y it is a dichotomous variable that indicates mammogram use or not, x it is a set of socio-economic covariates, D t is the dummy shows pre-and post ACA periods, u t is the random effect that is assumed to follow normal distribution and it is the error term. Next, besides changes in the use of preventive services, such as mammograms, as a result of health insurance changes, we hypothesize the possible improvement in the utilization of physician visits by breast cancer survivors. Use of physician services is reflected by count data. An excess number of zeros and the presence of strictly positive data points in the count datasets simply violate the main assumptions of standard Ordinary Least Square (OLS) specifications. One of the basic assumptions of OLS models is the normal distribution of the residual errors. For skewed continuous dependent variables, transformation of the dependent variable may produce errors that are approximately normal [20] . However, in the case of zero data points, categorical and discrete choices, transformation of dependent variables does not provide normally distributed error terms. Moreover, in such circumstances, OLS models produce negative predicted values that are theoretically incorrect [21, 22] . Recent literature has seen significant improvements in modelling count data by applying hurdle models [23] [24] [25] . To appropriately address the unobserved heterogeneity in the utilization of curative care and to provide a flexible modelling strategy, we implement zero-truncated Poisson log-normal regression models [26] . The log-likelihood function of the above model is shown as it follows:
In Equation (3), τ is the parameter to be estimated. The φ(ε i ) is the density function of standard normal distribution. The outcome variable (OOP prescription drug expenditure) is denoted by y i and ε i is the distributed error term.
Finally, we expect changes in out-of-pocket prescription drug expenditures post implementation of the ACA among breast cancer survivors. Modelling prescription drug expenditures requires much attention be given to the skewed distribution of the data points [27] . Past literature has heavily focused on log-transformations of expenditures or two-part modelling techniques [28] [29] [30] . However, the weak identification assumptions in each of the above methods provide less reliable estimates [31] . We empirically estimate the effects of the ACA on out-of-pocket prescription drug expenditures by applying a left-hand side Box-Cox power transformation [32] . This method has certain strengths that surpasses OLS models. First, unlike a log-transformation, it is much more flexible in terms of choosing powers for the skewed dependent variable [33] . Second, it provides more stabilized variances for the estimated coefficients [34] . The empirical model of interest takes the following form:
In Equations (3) and (4), y
is out-of-pocket prescription drug expenditures that are transformed with the power of λ and υ it is the error term. We report the result of Equation (3) in the results section of this paper. Also, the applied transformation is tested against base and log-forms as well.
The key assumption of our identification strategy is based on the fact that health insurance coverage, utilization of health care services and out-of-pocket health care expenditures would have followed similar trends among all racial and ethnic groups in the absence of ACA, which is an exogenous policy shock. By inspecting the graphs of all outcome variables before and after ACA implementation, we conclude that prior to 2010, racial and ethnic differences in outcomes were far from convergence and moving with a similar trend. Figure 1 depicts trends in uninsured status by race/ethnicity, from 2008 to 2015. The raw data indicate a disparity in health insurance coverage, with NHW least likely to be uninsured in the pre-ACA period. In 2010, the uninsured rates for NHB and Hispanics sharply declined, with the uninsured rate for NHB approximately zero. By 2011, NHW had the highest uninsured rate. By 2015, however, the uninsured rate converged to zero for all racial and ethnic groups. To complement the preliminary findings of our raw data analysis, we empirically estimate random effects multinomial logit (MNL) model and the results are presented in Tables 2 and 3 for the sub-periods A and B, respectively. For comparison, see Table A1 that reports public insurance coverage and uninsurance regression estimates using a logistic regression procedure that does not account for random effects.
Results
Uninsurance and the ACA
The random effects MNL model includes a dummy variable to account for the pre-or post-ACA time periods and controls for regional differences, socio-economic characteristics, health status and number of comorbidities. The table reports the relative risk ratios for a unit change in the predictor variable. Regardless of the post ACA sub-periods, the estimated coefficients of regressions indicate that the expected risk that NHB and Hispanic breast cancer survivors are uninsured is significantly lower post-ACA. In the first sub-period, although the relative risk of being uninsured is lower for both NHB and Hispanic breast cancer survivors, the gain is higher for NHB survivors. In the second sub-period, the risk of being uninsured declined for all racial and ethnic groups, with the gains highest for Hispanic survivors. Consistent with past literature [35, 36] on the coverage effect of the ACA, we reject the null hypothesis that the ACA has not improved health insurance coverage for racial and ethnic minority breast cancer survivors. Regardless of the post ACA sub-periods, the estimated coefficients of regressions indicate that the expected risk that NHB and Hispanic breast cancer survivors are uninsured is significantly lower post-ACA. In the first sub-period, although the relative risk of being uninsured is lower for both NHB and Hispanic breast cancer survivors, the gain is higher for NHB survivors. In the second sub-period, the risk of being uninsured declined for all racial and ethnic groups, with the gains highest for Hispanic survivors. Consistent with past literature [35, 36] on the coverage effect of the ACA, we reject the null hypothesis that the ACA has not improved health insurance coverage for racial and ethnic minority breast cancer survivors. Figure 2 illustrates trends in mammography use among breast cancer survivors by race/ethnicity, from 2008 to 2015. The raw data reveal that among breast cancer survivors, NHB and Hispanic survivors were more likely than NHW survivors to use mammograms pre-ACA. However, by 2012, NHB survivors had lower use and by 2015 Hispanic survivors had lower use than NHW survivors. Table 4 reports the random effects logistic regression results for mammography use within the last two years for breast cancer survivors. For comparison, see Table A2 that reports mammography utilization regression estimates using a logistic regression procedure that does not account for random effects. The regression models show that post-ACA the odds of mammography use were 1.1 times higher among NHB women during post-ACA subperiod A. During subperiod B, NHW and NHB had odds of mammography use that were 1.5 and 1.3 times higher. The subperiod B results were marginally significant among Hispanic women. These data are suggesting that disparities in mammography use decreased between NHW and NHB women. Table 4 reports the random effects logistic regression results for mammography use within the last two years for breast cancer survivors. For comparison, see Table A2 that reports mammography utilization regression estimates using a logistic regression procedure that does not account for random effects. The regression models show that post-ACA the odds of mammography use were 1.1 times higher among NHB women during post-ACA subperiod A. During subperiod B, NHW and NHB had odds of mammography use that were 1.5 and 1.3 times higher. The subperiod B results were marginally significant among Hispanic women. These data are suggesting that disparities in mammography use decreased between NHW and NHB women. Use of mammograms is not only crucial for breast cancer survivors but it significantly improves early detection and better clinical outcome for all women of child-bearing age. In an effort to test the possible improvement in overall utilization of mammograms as a result of the ACA, we report the trend analysis depicted in Figure 3 that explores disparities in mammography use for different racial and ethnic groups between 2008 and 2015. It seems that the ACA minimized the gap in mammography utilization among all racial and ethnic groups with an exception for Hispanic women that showed a sharp decline in use in 2013. To support the conclusions reached via the raw data trend analysis, we implement another random effects logistic regression model for the sample of women of all ages and include an interaction term between a dummy variable indicating whether the woman is a breast cancer survivor and time dummy that shows pre-and post-ACA (Table 5 ). This is because we suspect that mammography use may be different among women who have experienced breast cancer compared with women who are cancer free.
Mammography and the ACA
Comparing the post-ACA subperiod A to the pre-ACA time period, there were no differences in mammography use for any racial or ethnic group. During post-ACA time period B, Hispanic women were 7 times more likely to have a mammogram than during the pre-ACA period. The odds of mammography use were 14.6 and 17.2 times higher for Hispanic women with breast cancer when compared to cancer-free Hispanic women in the two post-ACA periods. The likelihood of using mammography by NHW and NHB breast cancer survivors were 2.1 and 2.5 times higher, respectively, than for cancer-free NHW and NHB women during post-ACA period A. Similarly, comparing the post-ACA subperiod B mammography use to that of the pre-ACA period, NHW and NHB breast cancer survivors use were 1.1 and 1.0 times higher during the later period or cancer-free NHW and NHB women during post-ACA period A. In sum, all Hispanic women, survivors and those cancer free, were much more likely to use mammograms during the post-ACA subperiod B than they were pre-ACA. For NHW and NHB women, higher use of mammography occurred during the post-ACA period for breast cancer survivors only but not for cancer free NHW and NHB women. respectively, than for cancer-free NHW and NHB women during post-ACA period A. Similarly, comparing the post-ACA subperiod B mammography use to that of the pre-ACA period, NHW and NHB breast cancer survivors use were 1.1 and 1.0 times higher during the later period or cancer-free NHW and NHB women during post-ACA period A. In sum, all Hispanic women, survivors and those cancer free, were much more likely to use mammograms during the post-ACA subperiod B than they were pre-ACA. For NHW and NHB women, higher use of mammography occurred during the post-ACA period for breast cancer survivors only but not for cancer free NHW and NHB women. Empirically speaking, the physician visit is a combination of two different decisions with separate data generating processes [37] . The first decision is to visit the physician and the second is the number of times to use physician visits. Figure 4 reports the final outcome of the two decisions. Table 5 reports the regression results that account for the two-part decision to use physician services, that is, it reports the factors influencing the number of physician visits controlling for the role of these factors in influencing the decision to use or not use physician services. The regression is a zerotruncated model that assumes the truncated data are distributed according to a Poisson distribution and the errors are log-normally distributed [26] . These estimates are robust, with marginal effects reported in Table 6 . For comparison, see Table A3 that reports Ordinary Least Squares regression estimates for physician visits and does not account for the two-part decision.
Physician Services Utilization and the ACA
According to the results reported in Table 6 , there is some support for a narrowing of the racial/ethnic gap in physician services use due to the ACA. The data indicate that post-ACA, NHB and NHW breast cancer survivors were more likely to have physician visits than pre-ACA, while the effect was larger for NHB survivors. Comparing the post-ACA subperiod B with the Pre-ACA period, NHB survivors were more likely to have physician visits, with the marginal effect higher in post-ACA period B than in post-ACA period A. There were no significant differences in Hispanic breast cancer survivors' physician visits post-ACA compared with the pre-ACA period. Empirically speaking, the physician visit is a combination of two different decisions with separate data generating processes [37] . The first decision is to visit the physician and the second is the number of times to use physician visits. Figure 4 reports the final outcome of the two decisions. Table 5 reports the regression results that account for the two-part decision to use physician services, that is, it reports the factors influencing the number of physician visits controlling for the role of these factors in influencing the decision to use or not use physician services. The regression is a zero-truncated model that assumes the truncated data are distributed according to a Poisson distribution and the errors are log-normally distributed [26] . These estimates are robust, with marginal effects reported in Table 6 . For comparison, see Table A3 that reports Ordinary Least Squares regression estimates for physician visits and does not account for the two-part decision. According to the results reported in Table 6 , there is some support for a narrowing of the racial/ethnic gap in physician services use due to the ACA. The data indicate that post-ACA, NHB and NHW breast cancer survivors were more likely to have physician visits than pre-ACA, while the effect was larger for NHB survivors. Comparing the post-ACA subperiod B with the Pre-ACA period, NHB survivors were more likely to have physician visits, with the marginal effect higher in post-ACA period B than in post-ACA period A. There were no significant differences in Hispanic breast cancer survivors' physician visits post-ACA compared with the pre-ACA period.
Prescription Drug Expenditures and the ACA
Another component of health care utilization is prescription drug expenditures. In MEPS, these expenditures include patient out-of-pocket payments, payments made by private insurance, Medicaid, Medicare and other sources. We report on out-of-pocket expenditures because they influence whether health care access is or is not be impeded and whether patients will have enough residual financial resources in order to finance other non-health care necessities. NHB and Hispanic cancer survivors have a higher risk of noncompliance with medication regimens when out-of-pocket medication costs are too high [38] . Exploring out-of-pocket prescription drug expenditures within a regression framework generates a slightly different conclusion related to changes in disparities in out-of-pocket prescription drug expenditures. Table 7 reports the results of a Box-Cox regression of out-of-pocket prescription drug expenditures. The graph of power transformation for each model associated with respective racial and ethnic groups is shown by Figures 6-8 . The Box-Cox powers are plotted against the value of the log-likelihood. As shown, the monotonic non-linear transformation is not rejected in favor of the base form and semi-log-transformation at 0.01% level of significance. For comparison, see Table  A4 that reports Ordinary Least Squares regression estimates for out-of-pocket prescription drug expenditures and does not use the Box-Cox procedure.
Post ACA, out-of-pocket prescription drug expenditures for NHB breast cancer survivors decreased significantly, thus narrowing racial disparities in out-of-pocket prescription drug expenditures. Exploring out-of-pocket prescription drug expenditures within a regression framework generates a slightly different conclusion related to changes in disparities in out-of-pocket prescription drug expenditures. Table 7 reports the results of a Box-Cox regression of out-of-pocket prescription drug expenditures. The graph of power transformation for each model associated with respective racial and ethnic groups is shown by Figures 6-8 . The Box-Cox powers are plotted against the value of the log-likelihood. As shown, the monotonic non-linear transformation is not rejected in favor of the base form and semi-log-transformation at 0.01% level of significance. For comparison, see Table A4 that reports Ordinary Least Squares regression estimates for out-of-pocket prescription drug expenditures and does not use the Box-Cox procedure.
Post ACA, out-of-pocket prescription drug expenditures for NHB breast cancer survivors decreased significantly, thus narrowing racial disparities in out-of-pocket prescription drug expenditures. Standard errors are reported in parenthesis and clustered at individual level. * p < 0.10, ** p < 0.05, *** p < 0.01; † Shows the base (comparison) category. 
Discussion
This paper explores the extent that the ACA, a system level intervention that focused on prevention and access to and continuity of care, could improve racial and ethnic equity in health care for breast cancer survivors. The robust estimates produced in these analyses using the longitudinal 
This paper explores the extent that the ACA, a system level intervention that focused on prevention and access to and continuity of care, could improve racial and ethnic equity in health care for breast cancer survivors. The robust estimates produced in these analyses using the longitudinal dimensions of MEPS 2008-2015 indicate that the ACA narrowed the racial and ethnic disparity in health insurance coverage, health care utilization and out-of-pocket prescription drug expenditures among the breast cancer survivors.
Our findings support hypotheses 1 and 2. The ACA led to an increase in insurance and a decline in uninsurance during both sub-period A and sub-period B for NHB and Hispanic breast cancer survivors. NHW survivors experienced declines in uninsurance in sub-period B only. The support for Hypothesis 3 was contingent on the post-ACA time period considered and varied by race/ethnicity. The hypothesis was supported for all Hispanic women, survivors and those cancer free, during the post-ACA subperiod B; they were much more likely to use mammograms than they were pre-ACA. Mammogram use for all NHW and NHB women did not increase post-ACA. Only NHB and NHW survivors had higher use of mammography and this occurred during both post-ACA periods. Hypothesis 4 was confirmed for NHB and NHW breast cancer survivors during post-ACA period A and for NHB survivors during post-ACA period B. However, there were no significant differences in Hispanic breast cancer survivors' physician visits post-ACA compared with the pre-ACA period. Hypothesis 5, a decrease in out-of-pocket prescription drug expenditures among survivors post-ACA was supported by or findings but only for NHB survivors.
The ACA impacted health care equity for NHB and Hispanic breast cancer survivors differently. The ACA improved equity in insurance coverage but had larger effects on NHB survivors compared to Hispanic breast cancer survivors during post-ACA subperiod A, while during post-ACA subperiod B the effects were larger for Hispanic survivors. Hispanic women generally increased mammography use post-ACA, while only NHB breast cancer survivors increased mammography use post-ACA. The ACA did not increase physician utilization for Hispanic breast cancer survivors, yet utilization increased for NHB survivors. The ACA significantly reduced out-of-pocket drug expenditures for NHB survivors but only marginally decreased out-of-pocket drug expenditures for Hispanic survivors.
Disaggregating the data in ways that we could explore the impact of the ACA in the early years versus the later periods was also important. The ACA implemented changes in access to preventive services and coverage for uninsurables during the early periods. In the later period (2014) (2015) , the ACA implemented Medicaid expansion, changes in the price of insurance coverage for those with incomes less than 400% of poverty and Medicare discounts. The early ACA period was associated with larger changes in the uninsured, primarily for NHB and Hispanic survivors. The later period reduced uninsurance for all groups. ACA changes made during the later time period significantly increased Hispanic survivors' use of mammograms. ACA changes made during both time periods were important for increasing NHB survivors' physician visits.
It is important to explore further the reason that only marginally significant decreases in disparities in out-of-pocket drug utilization and no changes in physician visits occurred post-ACA for Hispanic breast cancer survivors. Maybe in this case, other barriers to utilization, such as challenges in obtaining transportation to facilities and racial/ethnic differences in breast cancer treatment strategies, have some influences on this outcome.
A strength of our findings is that they are not solely based on self-reports. MEPS verifies insurance coverage, medical visits and all medical expenditures with provider claims data and other formal records. In addition, by using advanced statistical techniques, our estimates are robust.
One limitation of our analysis is that we do not have community level data that would allow us to discern the roles of factors, such as travel distance to facilities, in influencing decisions about physician services and mammography use. Also unknown are data on characteristics of physicians, presence of language barriers and types of social support available to the women as they seek to improve their health by utilizing the privileges provided by the ACA.
Conclusions
These results add to a growing body of literature that indicates that the ACA has had a positive impact on health care access and health outcomes [7, 13, 17, 36, 39] . We note that the ACA has also impacted another social concern for our health care system, racial and ethnic health care equity. Challenges to maintaining ACA health care equity gains exist. Two of these are proposals to remove the health insurance coverage mandate and the requirement that preexisting conditions do not exclude one from health insurance coverage. These provisions allowed the ACA to maintain affordable premiums and expand health insurance coverage to all income groups. Documenting the health equity impact of the various provisions of the ACA not only informs about its derived benefits but also, we discern the potential costs/negative repercussions of the legislations' repeal or modifications to specific provisions. Odds ratio reported for all the coefficients. Balanced repeated replication is applied to take into consideration of complex survey design. Standard errors are reported in parenthesis and clustered at individual level. High School (HS), General Education Diploma (GED); * p < 0.10, ** p < 0.05, *** p < 0.01. Odds ratio reported for all the coefficients. Balanced repeated replication is applied to take into consideration of complex survey design. Standard errors are reported in parenthesis and clustered at individual level. High School (HS), General Education Diploma (GED); * p < 0.10, ** p < 0.05, *** p < 0.01. Standard errors are reported in parenthesis and clustered at individual level. High School (HS), General Education Diploma (GED). * p < 0.10, ** p < 0.05, *** p < 0.01. Standard errors are reported in parenthesis and clustered at individual level. High School (HS), General Education Diploma (GED). * p < 0.10, ** p < 0.05, *** p < 0.01; † Shows the base (comparison) category.
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